Evidence map›Paper›PMID 28447301›Full record

ReviewPaediatric drugs2017

Management of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients.

Rudolph M Navari

Abstract readReview
PubMed Publisher
In one paragraph

Review in Paediatric drugs, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Review
  5. Article
  6. Article
  7. Combination of thalidomide andFrontiers in immunology · 2023
    Article
  8. Review
  9. Tapping into 5-HTInternational journal of molecular sciences · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Rudolph M NavariDivision of Hematology Oncology, School of Medicine, University of Alabama Birmingham, 1802 Sixth Avenue South, North Pavillion 2540K, Birmingham, AL, 35294, USA. rnavari@uabmc.edu.
University of Alabama at Birmingham · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemotherapy-induced nausea and vomiting (CINV) is associated with a significant deterioration in quality of life and is perceived by patients as a major adverse effect of the treatment. This review summarizes the safety and efficacy of current antiemetic agents for the prevention of CINV in children. Information on antiemetic prophylaxis for CINV in children was obtained from a literature review of current peer-reviewed articles and recent international guidelines. The literature review and the international antiemetic guidelines provide recommendations for use of specific antiemetics in children based on the emetogenicity of the chemotherapy. 5-Hydroxytryptamine-3 (5-HT

Indexed as

AntiemeticsAntineoplastic AgentsAntipsychotic AgentsChildHumansNauseaNeurokinin-1 Receptor AntagonistsPractice Guidelines as TopicQuality of LifeSerotonin 5-HT3 Receptor AntagonistsVomitingAntiemeticsAntineoplastic AgentsAntipsychotic AgentsNeurokinin-1 Receptor AntagonistsSerotonin 5-HT3 Receptor Antagonists

Identifiers

PMID28447301
OpenAlexW2606037640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.